CRISPR Base Editing Correction of TGFBI Mutations in Autosomal Dominant Corneal Dystrophies

Key Points

• The research aims to evaluate the potential of CRISPR base editing as a treatment for TGFBI mutations in corneal dystrophies.
• Utilized CRISPR adenine base editing in laboratory settings
• Targeted TGFBI mutations associated with corneal dystrophies
• Assessed safety and feasibility of the technique
• Successful correction of TGFBI mutations observed
• Indicated safety of the CRISPR base editing approach
• Promising results for future preclinical testing